Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8000
+0.0400 (5.26%)
At close: Mar 10, 2026
Market Cap690.88M -15.8%
Revenue (ttm)2.20B -1.8%
Net Income22.52M -81.5%
EPS0.02 -84.0%
Shares Out863.60M
PE Ratio35.01
Forward PEn/a
Dividend0.05 (6.58%)
Ex-Dividend DateMay 23, 2025
Volume413,000
Average Volume440,150
Open0.7500
Previous Close0.7600
Day's Range0.7400 - 0.8000
52-Week Range0.5000 - 1.0000
Beta0.55
RSI59.92
Earnings DateMar 25, 2026

About HKG:3737

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing services; and manages properties. Fu... [Read more]

Sector Healthcare
Founded 1993
Employees 2,488
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3737
Full Company Profile

Financial Performance

In 2024, HKG:3737's revenue was 2.21 billion, an increase of 8.05% compared to the previous year's 2.05 billion. Earnings were 95.21 million, a decrease of -41.51%.

Financial numbers in CNY Financial Statements